Novo Nordisk’s new CEO, Maziar Mike Doustdar, will contend with a challenging landscape in the U.S., where the company faces its biggest competitive threats

The company’s first non-Danish leader, Maziar Mike Doustdar, will face a challenging landscape in the U.S.